Primary |
Asthma |
52.9% |
Chronic Obstructive Pulmonary Disease |
19.4% |
Drug Use For Unknown Indication |
9.1% |
Bronchitis |
2.5% |
Dyspnoea |
2.5% |
Pneumonia |
2.5% |
Cough |
1.7% |
Asthma Prophylaxis |
1.2% |
Emphysema |
1.2% |
Respiratory Disorder |
1.2% |
Asthma Exercise Induced |
0.8% |
Hypersensitivity |
0.8% |
Lung Disorder |
0.8% |
Multiple Allergies |
0.8% |
Anxiety |
0.4% |
Chest Pain |
0.4% |
Erectile Dysfunction |
0.4% |
Fibromyalgia |
0.4% |
Influenza |
0.4% |
Intraocular Pressure Increased |
0.4% |
|
Pharmaceutical Product Complaint |
13.0% |
Product Quality Issue |
13.0% |
Tremor |
8.0% |
Vision Blurred |
6.0% |
Wheezing |
6.0% |
Pneumonia |
5.0% |
Weight Decreased |
5.0% |
Drug Ineffective |
4.0% |
Dry Throat |
4.0% |
Dyspnoea |
4.0% |
Vomiting |
4.0% |
Weight Increased |
4.0% |
Insomnia |
3.0% |
Laryngitis |
3.0% |
Oral Candidiasis |
3.0% |
Oropharyngeal Pain |
3.0% |
Rash |
3.0% |
Respiratory Disorder |
3.0% |
Throat Irritation |
3.0% |
Throat Tightness |
3.0% |
|
Secondary |
Asthma |
20.3% |
Drug Use For Unknown Indication |
15.2% |
Chronic Obstructive Pulmonary Disease |
13.9% |
Cardiac Disorder |
7.6% |
Antiemetic Supportive Care |
5.1% |
Dyspnoea |
5.1% |
Oesophageal Carcinoma |
5.1% |
Benign Prostatic Hyperplasia |
3.8% |
Hypertension |
3.8% |
Acute Sinusitis |
2.5% |
Antiplatelet Therapy |
2.5% |
Bronchitis |
2.5% |
Emphysema |
2.5% |
Hyperlipidaemia |
2.5% |
Anxiety |
1.3% |
Bladder Disorder |
1.3% |
Bronchitis Chronic |
1.3% |
Gastrointestinal Disorder |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Hiatus Hernia |
1.3% |
|
Tremor |
12.0% |
Drug Ineffective |
8.0% |
Dyspnoea |
8.0% |
Product Quality Issue |
8.0% |
Tonic Convulsion |
8.0% |
Cardiac Failure |
4.0% |
Dyspepsia |
4.0% |
Dysphonia |
4.0% |
Oral Candidiasis |
4.0% |
Panniculitis |
4.0% |
Rebound Effect |
4.0% |
Renal Failure Acute |
4.0% |
Sputum Discoloured |
4.0% |
Throat Irritation |
4.0% |
Thyroxine Free Increased |
4.0% |
Urinary Tract Infection |
4.0% |
Vomiting |
4.0% |
Weight Decreased |
4.0% |
Wheezing |
4.0% |
|
Concomitant |
Drug Use For Unknown Indication |
24.5% |
Asthma |
18.2% |
Chronic Obstructive Pulmonary Disease |
14.2% |
Product Used For Unknown Indication |
5.8% |
Depression |
4.1% |
Hypertension |
4.1% |
Dyspnoea |
3.0% |
Hypersensitivity |
2.8% |
Blood Cholesterol Increased |
2.7% |
Pain |
2.7% |
Emphysema |
2.5% |
Arthritis |
2.2% |
Back Pain |
1.8% |
Crohn's Disease |
1.8% |
Multiple Sclerosis |
1.8% |
Cardiac Disorder |
1.6% |
Diabetes Mellitus |
1.6% |
Rheumatoid Arthritis |
1.6% |
Type 2 Diabetes Mellitus |
1.6% |
Coronary Artery Disease |
1.5% |
|
Vomiting |
10.5% |
Dyspnoea |
9.5% |
Pneumonia |
7.4% |
Urinary Tract Infection |
6.3% |
Fistula |
5.3% |
Myocardial Infarction |
5.3% |
Pulmonary Embolism |
5.3% |
Vision Blurred |
5.3% |
Visual Acuity Reduced |
5.3% |
Weight Increased |
5.3% |
Skin Laceration |
4.2% |
Spinal Column Stenosis |
4.2% |
Weight Decreased |
4.2% |
Pruritus |
3.2% |
Renal Failure |
3.2% |
Skin Discolouration |
3.2% |
Thrombocytopenia |
3.2% |
Thrombosis |
3.2% |
Tremor |
3.2% |
Troponin Increased |
3.2% |
|